Females in Psychedelic Research: A Perspective for Advancing Research and Practice

Summary & key facts

This opinion paper says that changes in female hormones, like estradiol and progesterone, can affect brain chemistry and how people feel and think. Those hormone swings happen across the menstrual cycle and life stages. The authors argue these swings are likely to change how strong a psychedelic experience feels and how well it might work in therapy. They recommend that researchers track menstrual phase and measure hormones so studies are clearer and women can get better information before they take part in research or treatment. The paper calls for more study so care and research can be safer and fairer for women.

Key facts:

• The paper is an expert opinion, not a new experiment. It reviews existing ideas and cases to point out gaps in current research.
• Estradiol and progesterone, the main female sex hormones, interact with brain chemicals that psychedelics also affect, including serotonin, dopamine, GABA, and glutamate. This means hormones could change how psychedelics act in the brain.
• Hormone levels change across the menstrual cycle, and those changes can alter a specific serotonin receptor linked to psychedelics (called 5-HT2A). That could change how intense a psychedelic experience feels.
• Fluctuations in hormones also affect mood, thinking, and brain connectivity. These shifts could influence mindset before and during a psychedelic session, which matters for safety and outcomes.
• Because female hormones vary, not accounting for menstrual phase or hormone levels can make research results more mixed and harder to interpret.
• The authors recommend that studies and clinical programs track menstrual phase and, when possible, measure hormone levels. Doing this could help make results clearer and give women better information for informed consent.

Abstract

The influence of ovarian hormone fluctuations on neurochemistry, cognition, and psychological responses remains insufficiently examined in current psychedelic research and clinical protocols. Traditional practices and case studies underscore the importance of accounting for these factors in investigations of psychedelic effects. This opinion paper explores the critical intersections between female hormones and psychedelic experiences, informing improved research and practice. Estradiol (E2) and progesterone (P4), the primary ovarian hormones, modulate neurotransmitter systems central to psychedelic pharmacology, including serotonin (5-HT), dopamine, GABA, and glutamate. These hormonal interactions affect interhemispheric communication, synaptic plasticity, mood, cognition, and behavior. Fluctuations across the menstrual cycle influence 5-HT2A receptor expression and functional connectivity, potentially modulating both the subjective intensity and therapeutic efficacy of psychedelics. Additionally, oscillations in female hormones across the menstrual and life cycles affect mindset, a significant factor in safe and effective psychedelic use. These findings suggest that female hormonal variability may play a pivotal role in psychedelic experiences. Incorporating menstrual phase tracking and hormonal assays in both clinical trials and observational studies can reduce data variability, support individualized care, and improve informed consent practices. This would improve data integrity and ensure that women are fully informed about the potential influence of their hormonal state on their psychedelic experience, supporting truly informed consent. This paper emphasizes the need for an improved understanding of the complex interplay between female-specific biology and psychedelic pharmacodynamics to advance safe, ethical, and effective psychedelic research and therapies for women.

Topics

Chemical synthesis and alkaloids Diverse academic research themes Psychedelics and Drug Studies

Categories

Clinical Psychology Psychology Social Sciences

Tags

Art Engineering Engineering ethics Humanities Perspective (graphical) Practice research Psychology Sociology Visual arts

Substances

Other